Article
Beyond known mutations: Functional evidence for LRRK2 pathway activation in a subset of Parkinson’s disease patients
2025-12-09
Abstract excerpt
<title>Abstract</title> <p> Background Pathogenic <italic>LRRK2</italic> variants cause Parkinson’s disease (PD) through increased kinase activity, with <italic>VPS35</italic> p.D620N and other rare <italic>LRRK2</italic> variants showing similar effects. Findings in idiopathic PD suggest broader LRRK2 pathway involvement. As LRRK2-targeted therapies advance, identifying patients with elevated pathway acti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71cc9372-a9a4-5b24-8634-1a4df46310f3
- DOI
- 10.21203/rs.3.rs-8294746/v1
